Back to search

Poland· PL-100518098

Trabectedin Accord

A trabectedin product containing trabectedinum, registered in Poland by Accord Healthcare S.L.U.. The same ATC class is registered in 17 of our 19 countries.

ATC L01CX01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTrabectedin AccordATCL01CX01REGISTER NO.PL-100518098PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Trabectedin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01CX01 (trabectedin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose

Trabectedin · ATC L01CX01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trabectedin costs, country by country.

Normalised to the WHO defined daily dose (0.13 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trabectedin · price per daily dose (0.13 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$226.47
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Trabectedinum
Manufacturer
Accord Healthcare S.L.U.
Country
Poland (PL)
ATC code
L01CX01
ATC class
Trabectedin
Defined daily dose
0.13 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05056842800822

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

502 interactions on record for trabectedin.

Graded by severity as the source publishes them — 72 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Trabectedin · interactions on record

502 records

  • 72 severe
  • 430 moderate

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trabectedin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trabectedin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Trabectedin Ever Pharma, Trabectedin Stada
  • Belgium · Trabectedin Eg (Eurogenerics), Trabectedin Ever Pharma
  • Bulgaria · Трабектедин Ever Pharma
  • Czechia · Trabectedin Ever Pharma
  • Germany · Trabectedin Ever Pharma, Trabectedin Ratiopharm
  • Denmark · Trabectedin Teva, Trabektedin
  • Estonia · Trabectedin Ever Pharma
  • Spain · Trabectedina, Trabectedina Ever Pharma
  • Finland · Trabectedin, Trabectedin Ever Pharma
  • France · Trabectedin, Trabectedin Ever Pharma
  • United Kingdom (Northern Ireland) · Trabectedin Accord Healthcare, Trabectedin Genus Pharmaceuticals Ltd.
  • Greece · Trabectedin Ever Pharma, Trabectedin Teva
  • Croatia · Trabektedin Ever Pharma, Trabektedin Teva
  • Hungary · Trabectedin, Trabectedin Ever Pharma
  • Ireland · Trabectedin Ever Pharma
  • Iceland · Trabectedin Accord, Yondelis
  • Italy · Trabectedina Eg Spa, Trabectedina Ever Pharma
  • Liechtenstein · Trabectedin Accord, Yondelis
  • Lithuania · Trabectedin Ever Pharma
  • Luxembourg · Trabectedin Eg (Eurogenerics) Nv, Trabectedine Teva
  • Latvia · Trabectedin Ever Pharma
  • Netherlands · Trabectedine Ever Pharma, Trabectedine Teva
  • Norway · Trabectedin, Trabectedin Accord
  • Portugal · Trabectedina Ever Pharma, Trabectedina Teva
  • Romania · Trabectedin Ever Pharma, Trabectedin Teva
  • Sweden · Trabectedin Ever Pharma, Trabectedin Stada
  • Slovenia · Trabektedin Ever Pharma, Trabektedin Teva
  • Slovakia · Trabectedin Ever Pharma, Trabectedin Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8d9e3e10-6bb8-4b09-b7a4-772b35b67464
GET /v1/drugs/8d9e3e10-6bb8-4b09-b7a4-772b35b67464?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania koncentratu roztworu do infuzji",
  "source": "urpl",
  "strength": "1 mg",
  "packaging": "05056842800822 ¦ Rpz ¦ EU/1/24/1902/002 ¦ 162074\n1 fiol. 1 mg",
  "substance": "Trabectedinum 1 mg",
  "common_name": "Trabectedinum",
  "pl_product_id": "100518098",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about trabectedin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.